Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,397.00
Bid: 1,425.00
Ask: 1,450.00
Change: -43.00 (-2.99%)
Spread: 25.00 (1.754%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,440.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Important update regarding AGM

16 Apr 2020 13:00

RNS Number : 8053J
Indivior PLC
16 April 2020
 

Indivior PLC - Important update regarding AGM

 

On 13 March 2020, the Company published the notice convening its 2020 Annual General Meeting. Since its publication, the UK government has introduced measures to limit the impact of COVID-19, which includes social distancing measures and the prohibition of non-essential travel and public gatherings of more than two people (the 'Stay at Home measures').

 

The Board of Directors (the 'Board') of Indivior PLC have been monitoring the COVID-19 situation and have also taken account of the recent guidance issued by the Chartered Governance Institute regarding the impact of COVID-19 on AGMs. The introduction of the Stay at Home measures means that it will not be possible for shareholders to attend this year's Annual General Meeting ('AGM') in person.

 

Change of venue and arrangements

 

The AGM will no longer be held at the original venue and the meeting will now be held at the Company's registered office at 234 Bath Road, Slough, Berkshire, SL1 4EE. The date and time of the meeting, Thursday, 7 May at 3.00pm, is unchanged.

 

As a consequence of the Stay at Home measures, the arrangements for the AGM are as follows:

 

- attendance will be limited to essential personnel only to ensure that a quorum is present and to conduct the business of the AGM (attendance by these persons will be considered essential for work purposes);

- other shareholders will not be able to attend the AGM in person; and

- the format of the meeting will be restricted to the formal business of the AGM only.

 

Shareholders can submit questions to the Board in advance of the AGM by email to cosec@indivior.com. The Board will, where appropriate, answer shareholders' questions by publishing written responses on the Company's website at www.indivior.com.

 

The Board believes these measures are necessary and appropriate in light of the COVID-19 pandemic and, in particular, to protect the health and wellbeing of our employees, shareholders and the wider communities in which we operate.

 

Reminder to vote by proxy

 

The AGM is an important event in the Company's corporate calendar and provides an opportunity for shareholders to vote on important resolutions for the conduct of the business and affairs of the Company. Accordingly, the Board strongly encourages participation of all shareholders by:

1. Appointing the Chair of the AGM as their proxy.

2. Submitting a form of proxy as soon as possible and in any event by no later than 3.00pm (BST) on Tuesday, 5 May 2020 to ensure that their votes are counted. If a shareholder appoints a person other than the Chair of the AGM as their proxy, that other proxy will not be able to attend the AGM.

3. Re-submitting a new form of proxy to appoint the Chair of the AGM to replace any form already submitted which appoints a person other than the Chair of the AGM as their proxy.

A form of proxy may be submitted electronically by following the links provided at www.investorcentre.co.uk/eproxy or by returning the form to the Company's registrar, Computershare. Details of how to submit proxies are set out on page 9 of the Notice of AGM that was circulated to shareholders on 13 March 2020. Proxy instructions must be received no later than 3.00pm (BST) on Tuesday, 5 May 2020 or not less than 48 hours before the time of the holding of any adjourned AGM. For shares held through CREST, proxy appointments may be submitted via the CREST proxy voting system.

 

The Board will continue to monitor the situation and may, if necessary, make further changes to the arrangements for the AGM. Shareholders should therefore continue to monitor the Company's website and RNS announcements.

 

The Board would like to thank shareholders for their understanding during this challenging time.

 

Kathryn Hudson

Company Secretary

 

16 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKPBQFBKDAQD
Date   Source Headline
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 202311:51 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20233:33 pmRNSDirector/PDMR Shareholding
20th Nov 20232:55 pmRNSIndivior to Participate in Upcoming Investor Event
20th Nov 202312:56 pmRNSDirector/PDMR Shareholding
20th Nov 20239:37 amRNSHolding(s) in Company
17th Nov 202311:37 amRNSShare Repurchase Program
17th Nov 202310:00 amRNSHolding(s) in Company
17th Nov 20239:59 amRNSHolding(s) in Company
17th Nov 20237:00 amRNSAmendment to Relationship Agreement with Scopia
16th Nov 20232:00 pmRNSIndivior to Participate in Upcoming Conference
15th Nov 20232:54 pmRNSHolding(s) in Company
15th Nov 202310:23 amRNSHolding(s) in Company
10th Nov 202310:17 amRNSBlock listing Interim Review
9th Nov 20237:01 amRNSAppointment of Independent Non-Executive Director
9th Nov 20237:00 amRNS3rd Quarter Results
1st Nov 20234:00 pmRNSIndivior to Participate in Upcoming Conference
26th Oct 202311:51 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSIndivior settles Antitrust MDL with DPs
13th Oct 202312:14 pmRNSHolding(s) in Company
5th Oct 20233:30 pmRNSNotice of Results
21st Aug 20237:00 amRNSIndivior settles Antitrust MDL with End Payors
1st Aug 20234:00 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSHalf-year Report
26th Jul 20234:00 pmRNSHolding(s) in Company
24th Jul 20234:00 pmRNSHolding(s) in Company
10th Jul 20234:00 pmRNSHolding(s) in Company
5th Jul 20234:00 pmRNSHolding(s) in Company
30th Jun 20234:00 pmRNSDirector Declaration
29th Jun 20234:00 pmRNSHolding(s) in Company
27th Jun 202311:00 amRNSNotice of Results
21st Jun 20234:00 pmRNSHolding(s) in Company
16th Jun 20234:00 pmRNSHolding(s) in Company
15th Jun 20234:00 pmRNSHolding(s) in Company
14th Jun 20234:00 pmRNSHolding(s) in Company
14th Jun 20234:00 pmRNSHolding(s) in Company
13th Jun 20234:00 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSIndivior to Commence Trading on Nasdaq
7th Jun 20233:45 pmRNSHolding(s) in Company
2nd Jun 20235:17 pmRNSIndivior settles antitrust MDL with states and DC
1st Jun 20239:11 amRNSTotal Voting Rights
26th May 20234:20 pmRNSHolding(s) in Company
25th May 20232:30 pmRNSIndivior to Participate in Upcoming Conferences
24th May 20233:05 pmRNSHolding(s) in Company
23rd May 20236:05 pmRNSIndivior Files Form 20-F for US Listing
23rd May 20232:42 pmRNSHolding(s) in Company
23rd May 20238:30 amRNSHolding(s) in Company
23rd May 20237:00 amRNSUS FDA Approves OPVEE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.